Skip to content
Menu

Fate Therapeutics, Inc. FATE

Full chart Compare
Set alert

Price alert · FATE

All alert types
1.01 USD -0.04 (-3.81%)

Regular-session close

1.05 +0.04 +3.79%

After hours · Nov 19, 7:13 PM ET

1.01 Day range 1.07
0.95 52-week range 3.23
YTD
+3.06%
1 year
-3.81%

Revenue & Expenses

Revenue Profit Costs
Other Income$11.39MOther Operating Income$12.90MNet Loss$136.31MCost of Revenue$12.90MExpenses$160.60MGross Loss$6.25MSelling, General & Admin$46.52MResearch & Development$107.83MRevenue$6.65M

Latest period ending Dec 31, 2025 · select a line to chart its full history

FATE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.65M13.63M63.53M96.30M55.85M
6.65M13.63M63.53M96.30M55.85M
-147.70M-210.28M-190.51M-308.39M-216.99M
-136.31M-186.26M-160.93M-281.72M-212.15M
-1.15-1.64-1.64-2.91-2.24
FATE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
56.85M46.28M57.05M76.56M148.81M
318.94M440.69M506.22M705.56M921.46M
111.75M121.97M137.80M221.62M242.62M
77.85M85.27M103.54M109.34M114.82M
207.18M318.73M368.42M483.94M678.84M
FATE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-106.08M-122.87M-132.26M-248.21M-162.87M
111.17M12.22M112.67M166.75M-324.02M
5.49M99.89M85.00K9.21M453.13M
-5.59M-730.00K-6.15M-35.57M-50.70M
10.57M-10.76M-19.51M-72.25M-33.76M